scholarly article | Q13442814 |
P2093 | author name string | Carly Bridden | |
Debbie M Cheng | |||
Judith I Tsui | |||
Howard Libman | |||
Jeffrey Samet | |||
P2860 | cites work | The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations | Q25938996 |
Pain responses in methadone-maintained opioid abusers | Q28140910 | ||
Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent | Q28190901 | ||
Pain in ambulatory HIV-infected patients with and without intravenous drug use. | Q53338567 | ||
Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. | Q53450437 | ||
Symptom prevalence, characteristics, and distress in AIDS outpatients. | Q53539578 | ||
Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. | Q54074176 | ||
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. | Q55240560 | ||
Hyperalgesic responses in methadone maintenance patients | Q59287129 | ||
Multidimensional Aspects of Pain in HIV-Infected Individuals | Q63953585 | ||
Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif | Q73466642 | ||
Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients | Q77424223 | ||
Panic disorder and pain in a national sample of persons living with HIV | Q79920134 | ||
Hepatitis C in the HIV-Infected Person | Q28206126 | ||
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients | Q28274666 | ||
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial | Q28298301 | ||
A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity | Q29547290 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Emerging evidence of hepatitis C virus neuroinvasion | Q31013540 | ||
A closer look at pain and hepatitis C: preliminary data from a veteran population. | Q31114850 | ||
Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. | Q33331448 | ||
Morbidity of chronic hepatitis C as seen in a tertiary care medical center | Q33498295 | ||
Depression and pain comorbidity: a literature review | Q33973797 | ||
Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines | Q34283828 | ||
Illness burden mediates the relationship between pain and illicit drug use in persons living with HIV. | Q34341778 | ||
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. | Q34369407 | ||
Development and validation of a self-completed HIV symptom index. | Q34466580 | ||
Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problems | Q35069899 | ||
Fibromyalgia, hepatitis C infection, and the cytokine connection | Q35208432 | ||
Pain and the use of outpatient services among persons with HIV: results from a nationally representative survey | Q35634362 | ||
Clinical practice. Unhealthy alcohol use. | Q36036196 | ||
Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment | Q36080601 | ||
Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory | Q36274123 | ||
"Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids | Q36464466 | ||
Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? | Q36490874 | ||
Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha | Q36590620 | ||
Cognitive dysfunction in chronic hepatitis C: a review | Q36912200 | ||
Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. | Q37116161 | ||
Cytokine regulation in animal models of neuropathic pain and in human diseases. | Q37134876 | ||
Experience of pain among women with advanced HIV disease | Q37472839 | ||
A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse | Q39454002 | ||
Correlates of hepatitis C virus infections among injection drug users. | Q40453200 | ||
Pain syndromes and etiologies in ambulatory AIDS patients | Q41469573 | ||
Drinking to cope, emotional distress and alcohol use and abuse: a ten-year model. | Q43591010 | ||
Depression and drug use impact health status among marginally housed HIV-infected individuals | Q43667157 | ||
The association of persistent pain with out-patient addiction treatment outcomes and service utilization | Q43788730 | ||
Psychiatric disorders among veterans with hepatitis C infection | Q44081498 | ||
Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire | Q44798054 | ||
Pain and use of alcohol to manage pain: prevalence and 3-year outcomes among older problem and non-problem drinkers | Q46512046 | ||
Depression, fatigue, and functional disability in patients with chronic hepatitis C. | Q46556569 | ||
Patient-related barriers to pain management in ambulatory AIDS patients. | Q50871459 | ||
Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. | Q50953377 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis C | Q154869 |
Hepatitis C virus | Q708693 | ||
P304 | page(s) | 820-827 | |
P577 | publication date | 2012-01-24 | |
P1433 | published in | AIDS Care | Q15755470 |
P1476 | title | Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults | |
P478 | volume | 24 |
Q33756904 | Biopsychosocial factors associated with pain in veterans with the hepatitis C virus |
Q36733235 | Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy |
Q59358316 | Depression, fatigue and neurocognitive deficits in chronic hepatitis C |
Q35875495 | Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. |
Q36652976 | Pain Symptoms Associated with Opioid Use among Vulnerable Persons with HIV: An exploratory study with implications for palliative care and opioid abuse prevention |
Q35503257 | Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection |
Q36399193 | Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis |
Q57169109 | Psychosocial Factors Associated with Persistent Pain in People with HIV: A Systematic Review with Meta-Analysis |
Q88271288 | Rheumatic diseases in HIV-infected patients in the post-antiretroviral therapy era: a tertiary care center experience |
Search more.